Abstract
Objective
To discuss the relationship between Bax expression level and lung cancer cell apoptosis induced by peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists.
Methods
RT-PCR and Western blot analysis were used to detect PPAR-γ expression in the lung cancer cells, and TUNEL was used to detect apoptosis induced by PPAR-γ agonists, while in situ hybridization and immunohistochemistry were used to monitor the changes of Bax mRNA and protein expression levels after apoptosis induced.
Results
PPAR-γ expression was detectable in two kinds of lung cancer cells (including Non-small cell lung cancer and small cell lung cancer), and PPAR-γ agonists could inhibit lung cancer growth through inducing apoptosis. The apoptostic rates in control group, 15d-PGJ2 group and ciglitazone group were (1.86±0.49)%, (25.8±2.9)%, and (17.3±1.9)% (P<0.01) respectively; Bax mRNA expression rates in the three groups were (8.75±1.36)%, (66.2±12.86)%, and (29.5±6.5)% (P<0.01) respectively; Bax protein expression rates in the three groups were (9.2±1.45)%, (63±10.4)%, and (34.5±6.0)% (P<0.05) respectively.
Conclusion
PPAR-γ is predicted to be a new target in treating lung cancer in the future, and Bax is most likely to work in treating lung cancer apoptosis induced by PPAR-γ agonists as a factor to induced apoptosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Fajas L, Debril MB, Auwerx J,et al. Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis. J Mol Endocrinol, 2001, 27: 1–9.
Wood I. Pro-inflammatory mechanisms of a nonsteroidal anti-inflammatory drug. Trends Endocrinol Metab, 2002, 13: 53.
Eibl G, Wente MN, Reber HA,et al. Peroxisome proliferator-activated receptor gamma induces pancreatic cancer cell apoptosis. Biochem Biophys Res Commun, 2001, 287: 522–529.
Jiang WG, Redern A, Bryce RP,et al. Peroxisome proliferator activated receptor-gamma (PPAR-gamma) mediates the action of gamma linolenic acid in breast cancer cells. Prostaglandins Leukot Essent Fatty Acids, 2000, 62: 119–127.
Wijnhoven BP, Lindstedt EW, Abbou M,et al. Molecular genetic analysis of the von Hippel-Lindau and human peroxisome proliferator-activated receptor gamma tumor-suppressor genes in adenocarcinomas of the gastroesophageal junction. Int J Cancer, 2001, 94: 891–895.
Tsubouchi Y, Sano H, Kawahito Y,et al. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis. Biochem Biophys Res Commun, 2000, 270: 400–405.
Satoh T, Toyoda M, Hoshino H,et al. Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells. Oncogene, 2002, 21: 2171–2180.
Inoue K, Kawahito Y, Tsubouchi Y,et al. Expression of peroxisome proliferator-activated receptor (PPAR)-gamma in human lung cancer. Anticancer Res, 2001, 21: 2471–2476.
Carlos GF, Simone WS, Godefridus JP,et al. Chemotherapy triggers apoptosis in a caspase-8-dependent and mitochondria controlled manner in the non-small cell lung cancer cell line NCI-H460. Cancer Res, 2000, 60: 7133–7141.
Wood DE, Thomas A, Devi LA,et al. Bax cleavage is mediated by calpain during drug-induced apoptosis. Oncogene, 1998, 17: 1069–1078.
Author information
Authors and Affiliations
Corresponding author
Additional information
This proiect was supported by a grant from Hubei Provincial Natural Sciences foundation (No. 98J102).
Rights and permissions
About this article
Cite this article
Min, Z., Ping, Z., Ming, B. et al. Expression of bax in lung cancer cell apoptosis induced by peroxisome proliferator-activated receptor-γ agonists. Chin. -Ger. J. Clin. Oncol. 1, 190–193 (2002). https://doi.org/10.1007/BF02838430
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02838430